| 000 | 01090 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250515141208.0 | ||
| 264 | 0 | _c20081218 | |
| 008 | 200812s 0 0 eng d | ||
| 022 | _a1538-7836 | ||
| 024 | 7 |
_a10.1111/j.1538-7836.2008.03124.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFitzmaurice, D A | |
| 245 | 0 | 0 |
_aOral anticoagulation should be managed in the community with treatment aimed at standard therapeutic targets and increased recall intervals. _h[electronic resource] |
| 260 |
_bJournal of thrombosis and haemostasis : JTH _cOct 2008 |
||
| 300 |
_a1645-6 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Journal Article | ||
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 |
_aAtrial Fibrillation _xcomplications |
| 650 | 0 | 4 | _aCommunity Health Centers |
| 650 | 0 | 4 | _aDisease Management |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 773 | 0 |
_tJournal of thrombosis and haemostasis : JTH _gvol. 6 _gno. 10 _gp. 1645-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1538-7836.2008.03124.x _zAvailable from publisher's website |
| 999 |
_c18318238 _d18318238 |
||